Sharekhan's research report on Coromandel International
Q3FY2023 PAT of Rs. 527 crore (up 38% y-o-y) was 22% above our estimate led by strong performance from nutrients and other allied business offsetting muted growth from the CPC business. OPM, at 9.4%, lagged our estimate due to lower gross margins and higher other expenses. Revenue/EBIT from nutrients and other allied businesses grew strongly by 72%/59% y-o-y to Rs. 7,710 crore/Rs. 697 crore led by higher subsidy support and better realisation. However, CPC revenue/EBIT growth of 5%/-13% y-o-y was muted as growth in domestic formulation and B2B businesses was offset by headwinds in export markets. The management guided for better fertilizer margins of Rs. 5,500-6,000/mt in the coming years led by declining raw material prices and increasing cost efficiencies. It had earlier guided for margins Rs. 5,500/mt for FY23. Phosphoric acid price declined to $1,050/mt in Q3FY23 versus $1,175/tonne in Q2FY23 and the same bodes well for fertiliser margins.
Outlook
We maintain Coromandel to Buy with an unchanged PT of Rs. 1,155 as margin/earnings outlook has improved as input price pressures ease and valuation of 11.7x/10.9x FY24E/FY25E EPS seems reasonable.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.